Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: IIT RESEARCH INSTITUTE
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-09-23 to 2022-08-31
Current total value of award: $588615
Description: SUPPORT FOR THE PRECLINICAL DEVELOPMENT OF EIF4A INHIBITORS ROCAGLAMIDE AND DIDESMETHYLROCAGLAMIDE. (TOXICOLOGY SERVICES TO SUPPORT PRECLINICAL DRUG DEVELOPMENT)